Skip to main content

The Cough Cylinder: a tool to study measures against airborne spread of (myco-) bacteria

Buy Article:

$34.78 + tax (Refund Policy)

BACKGROUND: ‘Covering your cough’ reduces droplet number, but its effect on airborne pathogen transmission is less clear. The World Health Organization specifically recommends cough etiquette to prevent the spread of Mycobacterium tuberculosis, but implementation is generally poor and evidence supporting its value is lacking.

METHODS: We constructed a model to assess ‘real life’ transmission risk by counting viable pathogens from aerosols produced by coughing patients, thus allowing the assessment of outward protection measures in a standardised fashion. During the validation process, we focused on rod-shaped bacteria as surrogates for M. tuberculosis.

RESULTS: The Cough Cylinder enabled us to sample Pseudomonas aeruginosa, Escherichia coli and mycobacteria from aerosols produced by patients with cystic fibrosis, primary ciliary dyskinesia and tuberculosis. Pathogens in droplets and in airborne particles could be sampled. Delayed air sampling allowed specific measurement of persistent airborne particles.

CONCLUSION: This novel experimental system allows measurement of aerosol pathogen spread in a highly standardised fashion. It also offers the possibility to assess the impact of different interventions to limit aerosol transmission.

Keywords: aerosol transmission; cough etiquette; infection control; respiratory hygiene; tuberculosis

Document Type: Research Article

Affiliations: 1: Department of Pediatric Infectious Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 2: Sydney Institute for Emerging Infectious Diseases and Biosecurity & The Children's Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia 3: Department of Clinical Microbiology of the University Centre for Chronic Diseases Dekkerswald and Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 4: Department of Respiratory Diseases of the University Centre for Chronic Diseases Dekkerswald and Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 5: TNO, Rijswijk, The Netherlands 6: Department of Clinical Microbiology of the University Centre for Chronic Diseases Dekkerswald and Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, The Netherlands 7: Department of Paediatrics and Child Health and Children's Infectious Diseases Clinical Research Unit, Tygerberg Children's Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa

Publication date: 01 January 2013

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content